文献速递间质性肺疾病

间质性肺异常:诊断与管理方法的叙述性综述

Interstitial Lung Abnormality: Narrative Review of the Approach to Diagnosis and Management.
PubMed 文献 · Chest · 2024-10-10

本文提出一种间质性肺异常(ILA)的算法化诊疗路径:放射科识别CT上的ILA模式并排除不相关表现,确认病变占据非下垂肺区>5%后分类为非胸膜下、胸膜下非纤维化或胸膜下纤维化;临床医生结合症状、肺生理和ILD危险因素将患者分为ILA、ILD高危、可能ILD或ILD,再据进展风险决定监测策略。

要点

  • CT确认ILA需病变占据非下垂肺区>5%,并分为非胸膜下、胸膜下非纤维化、胸膜下纤维化三型。
  • 结合症状、肺生理和ILD危险因素,将患者分为ILA、ILD高危、可能ILD或ILD。
  • 有进展风险特征者建议前瞻性系列监测,无者建议反应性监测;确诊ILD后按疾病特异性管理。

核心结论

  • 提出一种算法化方法用于识别和管理间质性肺异常患者。

研究设计与样本

  • 叙述性综述,未报告系统检索范围或样本量。

主要发现

  • 放射科识别CT上提示ILA模式的表现并排除不一致表现,确认病变占据非下垂肺区>5%后确定ILA的放射学模式。
  • ILA放射学模式分类为非胸膜下、胸膜下非纤维化和胸膜下纤维化。
  • 临床医生需判断患者症状和/或肺生理异常是否可归因于这些放射学改变。
  • 基于症状、生理评估和ILD危险因素,将患者分类为ILA、ILD高危、可能ILD或ILD。
  • 对ILA患者,多学科讨论评估提示进展风险增加的特征,有则建议前瞻性系列监测,无则建议反应性监测;确诊ILD后管理按疾病特异性进行。

关键数值与推荐

  • ILA的CT确认标准为病变占据非下垂肺区>5%。
  • ILA放射学模式分为非胸膜下、胸膜下非纤维化和胸膜下纤维化三类。
  • 临床分类包括ILA、ILD高危、可能ILD和ILD四类。
  • 进展风险增加者建议前瞻性系列监测,无进展风险特征者建议反应性监测。

临床怎么用

  • 放射科按CT表现识别ILA模式并确认病变占据非下垂肺区>5%后分类。
  • 临床医生结合症状、肺生理和ILD危险因素对患者进行ILA、ILD高危、可能ILD或ILD分类。
  • 对ILA患者通过多学科讨论评估进展风险特征,据此选择前瞻性或反应性监测策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TOPIC IMPORTANCE: As interstitial lung abnormalities (ILAs) are increasingly recognized on imaging and in clinical practice, identification and appropriate management are critical. We propose an algorithmic approach to the identification and management of patients with ILAs. REVIEW FINDINGS: The radiologist initially identifies chest CT scan findings suggestive of an ILA pattern and excludes findings that are not consistent with ILAs. The next step is to confirm that these findings occupy > 5% of a nondependent lung zone. At this point, the radiologic pattern of ILA is identified. These findings are classified as non-subpleural, subpleural nonfibrotic, and subpleural fibrotic. It is then incumbent on the clinician to ascertain if the patient has symptoms and/or abnormal pulmonary physiology that may be attributable to these radiologic changes. Based on the patient's symptoms, physiologic assessment, and risk factors for interstitial lung disease (ILD), we recommend classifying patients as having ILA, at high risk for developing ILD, probable ILD, or ILD. In patients identified as having ILA, a multidisciplinary discussion should evaluate features that indicate an increased risk of progression. If these features are present, serial monitoring is recommended to be proactive. If the patient does not have imaging or clinical features that indicate an increased risk of progression, then monitoring is recommended to be reactive. If ILD is subsequently diagnosed, the management is disease specific. SUMMARY: We anticipate this algorithmic approach will aid clinicians in interpreting the radiologic pattern described as ILA within the clinical context of their patients.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Kattih Z, Bade B, Hatabu H, et al. Interstitial Lung Abnormality: Narrative Review of the Approach to Diagnosis and Management. Chest. 2024. PMID: 39393485. doi:10.1016/j.chest.2024.09.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。